Constipation among workers with depression/anxiety: a retrospective study using a claims database and survey data in Japan

• Published in: BMJ open Vol. 14; no. 11; p. e083668
• Main Authors: Karasawa, Yusuke, Nozawa, Kazutaka, Nomoto, Keisuke, Fukudo, Shin
• Format: Journal Article
• Language: English
• Published: England British Medical Journal Publishing Group 19.11.2024; BMJ Publishing Group LTD; BMJ Publishing Group
• Subjects: Adult; Anxiety - epidemiology; Anxiety disorders; Codes; Constipation; Constipation - epidemiology; Databases, Factual; Depression & mood disorders; Depression - epidemiology; Employees; Employment; Female; Functional bowel disorders; GASTROENTEROLOGY; Gastroenterology and Hepatology; Generalized anxiety disorder; Health insurance; Health promotion; Humans; Irritable bowel syndrome; Japan - epidemiology; Lifestyles; Male; Mental depression; Mental disorders; Middle Aged; Narcotics; Original Research; Patient Reported Outcome Measures; Population; Prescription drugs; Prevalence; Productivity; Psychotropic drugs; Quality of Life; Questionnaires; Retrospective Studies; Surveys and Questionnaires; Young Adult; Japan; Quality of Life; Anxiety disorders; Depression & mood disorders; Functional bowel disorders; GASTROENTEROLOGY; Patient Reported Outcome Measures
• ISSN: 2044-6055; 2044-6055
• DOI: 10.1136/bmjopen-2023-083668

ObjectivesTo investigate the prevalence, associated factors, treatment status and burden of constipation in workers with depression or anxiety.Study designThis was a retrospective observational study using a pre-existing database.SettingClaims data from October to November 2022 and data from the survey conducted in November 2022 were extracted from the database.ParticipantsThis study included self-reported workers who completed the survey, after excluding those with major mental disorders diagnosed as distinct from depression or anxiety and constipation due to organic diseases identified by International Classification of Diseases (ICD-10) codes.Outcome measuresThe subjects were divided into three groups: treated depression/anxiety, untreated depression/anxiety and no depression/anxiety. The prevalence of constipation, factors associated with constipation and medications prescribed for constipation were analysed. Work productivity and quality of life (QOL) were compared between three subgroups based on constipation status: treated constipation, untreated constipation and no constipation subgroup.ResultsOf the 18 585 respondents in the analysis population, 950 respondents (5.1%) were classified into the treated depression/anxiety group, 6035 respondents (32.5%) into the untreated depression/anxiety group and the remaining respondents into the no depression/anxiety group (11 600 (62.4%)). The prevalence of constipation was 22.5% in the treated group, 22.3% in the untreated group and 10.4% in the no depression/anxiety group, respectively. Depression and anxiety severity were independently associated with an increased risk of constipation. In all groups, the most commonly prescribed drug class was osmotic laxatives. Work productivity and QOL tended to indicate a greater burden in the untreated constipation subgroup than in the treated or no constipation subgroups.ConclusionsThe prevalence of constipation was twice as high if workers had depression/anxiety. Considering that the comorbidity of constipation with mental disorders may increase multiple burdens, appropriate medical interventions are required to treat both mental (depression/anxiety) and physical (constipation) conditions. This should be widely recognised by physicians and employers.